Evaluating brain imaging methods after non-traumatic intracranial hemorrhage
Prospective Assessment of Brain Imaging After Aneurysmal of AVM-related Intracranial Hemorrhage
Erasme University Hospital · NCT05276934
This study is testing different brain imaging methods to see how well they can help doctors understand blood flow in patients over 18 who have had a brain bleed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Erasme University Hospital (other) |
| Locations | 1 site (Brussel) |
| Trial ID | NCT05276934 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate various diagnostic methods for assessing brain perfusion in patients who have experienced non-traumatic intracranial hemorrhage, such as those caused by ruptured aneurysms or arteriovenous malformations. The study will involve brain computed tomography as part of the assessment process. It focuses on patients aged 18 and older who have had an intracranial hemorrhage and are eligible for imaging. The goal is to gather data on the effectiveness of these imaging techniques in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have experienced non-traumatic intracranial hemorrhage.
Not a fit: Patients with traumatic intracranial hemorrhage or those who refuse imaging will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve diagnostic accuracy and management strategies for patients with non-traumatic intracranial hemorrhage.
How similar studies have performed: While this study builds on existing imaging techniques, its specific focus on non-traumatic intracranial hemorrhage represents a novel approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
i. Inclusion Criteria 1. Age ≥ 18 years 2. Non-traumatic intracranial hemorrhage (subarachnoid hemorrhage secondary to a ruptured aneurysm or AVM, unknown cause, per procedural bleed) 3. In case of ruptured aneurysm, AVM or other etiology : need to be secured with surgical clipping or endovascular intervention if judged possible 4. No contra-indication to perfusion imaging 5. Subject or legal representative is able and willing to give informed consent. ii. Exclusion Criteria 1. Traumatic intracranial hemorrhage 2. Contra-indication to imaging or patient's refusal.
Where this trial is running
Brussel
- Erasme Hospital — Brussel, Belgium (RECRUITING)
Study contacts
- Principal investigator: Adrien Guenego, MD — Erasme University Hospital
- Study coordinator: Comite ethique hopital Erasme
- Email: comite.ethique@erasme.ulb.ac.be
- Phone: 003225553707
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Aneurysm, Ruptured, Aneurysmal Subarachnoid Hemorrhage, Arteriovenous Malformations, Intracranial Aneurysm, Intracranial Hemorrhages